Selvita S.A. Logo

Selvita S.A.

Preclinical CRO offering integrated drug discovery and development services for life sciences.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Selvita S.A. is one of Europe's largest preclinical Contract Research Organizations (CROs), providing integrated services for the pharmaceutical, biopharmaceutical, and chemical industries. The company specializes in drug discovery and development, with a mission to bridge the gap between early discovery and the clinical stages. Selvita offers a comprehensive scope of solutions, including high-quality research and development support and advanced analytical services. It supports client projects across various therapeutic areas, helping to accelerate the development of new therapies for patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 10:16
Director's Dealing
Powiadomienie 2
Polish 4.3 KB
2025-10-03 10:16
Director's Dealing
Powiadomienie 1
Polish 4.3 KB
2025-10-03 10:16
Major Shareholding Notification
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 808 bytes
2025-09-29 00:04
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
English 2.6 KB
2025-09-29 00:04
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
Polish 2.1 KB
2025-09-23 00:03
Regulatory News Service
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
English 2.5 KB
2025-09-23 00:03
Regulatory News Service
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
Polish 2.0 KB
2025-09-19 20:08
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
English 6.2 KB
2025-09-19 20:08
Regulatory News Service
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG /…
Polish 6.1 KB
2025-09-18 00:03
Audit Report / Information
Independent registered auditor's report on the review of the interim condensed …
English 105.2 KB
2025-09-18 00:03
Audit Report / Information
Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego skon…
Polish 330.4 KB
2025-09-18 00:03
Audit Report / Information
Independent registered auditor's report on the review of the condensed standalo…
English 127.7 KB
2025-09-18 00:03
Audit Report / Information
Raport niezależnego biegłego rewidenta z przeglądu skróconego jednostkowego spr…
Polish 330.0 KB
2025-09-18 00:03
Interim Report
Śródroczne jednostkowe sprawozdanie finansowe H1
Polish 1.0 MB
2025-09-18 00:03
Interim Report
Interim Consolidated Financial Statements H1
English 1.1 MB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.